Trial Information

Summary: Prostate Cancer Prevention Clinical Trial

The Doctors of Staten Island Urological Research, PC are seeking men concerned with prostate health for participation in a prostate cancer prevention clinical research study. This study is testing the safety and effectiveness of an investigational use of a FDA approved drug in reducing the risk of prostate cancer.

Eligibility Criteria:

  • Men must be 50 to 75 years old and may suffer symptoms such as difficulty urinating and frequent urge to urinate.
  • Participants must have had only one negative prostate biopsy within the past 6 months.

Volunteers meeting these and other criteria will be asked to undergo a screening visit to determine eligibility. All office visits and medical evaluations related to this study will be provided to qualified participants at no charge.

Contact:

Maureen Lampo
Staten Island Urological Research, P.C.
1800 Clove Road
Staten Island, NY 10304
Telephone: 718-720-6040
Fax: 718-720-6523
Email:

Profile Page: Staten Island Urological Research, P.C., Staten Island, NY

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:43:38 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA